by John Finey | Aug 20, 2020 | Blog
Covid-19 will become synonymous with ‘working from home’ and has caused many businesses to re-consider how they operate day to day. So given that the required technology has been around for some years, why has it taken Covid-19 to prompt this re-think…
by John Finey | Aug 20, 2020 | Blog
I am not a fan of business jargon, but I came across this term some years ago, not sure where. Whilst I am not even sure of the original meaning it has stuck with me as a possible name for an area of business analysis that experience would show, many organisations ignore or at least don’t do very well…
by John Finey | Jun 25, 2020 | Blog
With a number of reports from over the pond of Mr Trump praising China, even in areas where I think most sane people will think ‘there is room for improvement’, I am a little reluctant to join in but credit where it is due…
by John Finey | Mar 18, 2019 | Blog
With everything going on at the moment it is easy to forget that there are things other than Brexit happening. An important one for the pharma supply chain is the scheduling of Pregabalin and Gabapentin as Class C, schedule 3 controlled drugs from 1st April 2019….
by John Finey | Aug 21, 2018 | Blog, Brexit, Training
I am sure plenty has been written and said about what I am sure many will see as an additional burden on wholesalers, this simple post is to help provide clarity about the scope of the regulations…